| A mechanism converting psychosocial stress into mononuclear cell activation A Bierhaus, J Wolf, M Andrassy, N Rohleder, PM Humpert, D Petrov, ... Proceedings of the National Academy of Sciences 100 (4), 1920-1925, 2003 | 1137 | 2003 |
| ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? D Petrov, C Mansfield, A Moussy, O Hermine Frontiers in aging neuroscience 9, 68, 2017 | 459 | 2017 |
| Current research therapeutic strategies for Alzheimer’s disease treatment J Folch, D Petrov, M Ettcheto, S Abad, E Sánchez-López, ML García, ... Neural plasticity 2016, 2016 | 326 | 2016 |
| Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease I Pedrós, D Petrov, M Allgaier, F Sureda, E Barroso, C Beas-Zarate, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014 | 201 | 2014 |
| High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents D Petrov, I Pedrós, G Artiach, FX Sureda, E Barroso, M Pallàs, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …, 2015 | 168 | 2015 |
| Review of the advances in treatment for Alzheimer disease: strategies for combating β-amyloid protein J Folch, M Ettcheto, D Petrov, S Abad, I Pedrós, M Marin, J Olloquequi, ... Neurología (English Edition) 33 (1), 47-58, 2018 | 145 | 2018 |
| Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-κB activation in PBMCs G Rudofsky Jr, P Reismann, S Schiekofer, D Petrov, M Von Eynatten, ... Hormone and metabolic research 36 (09), 630-638, 2004 | 89 | 2004 |
| Masitinib for the treatment of mild to moderate Alzheimer’s disease J Folch, D Petrov, M Ettcheto, I Pedros, S Abad, C Beas-Zarate, ... Expert review of neurotherapeutics 15 (6), 587-596, 2015 | 82 | 2015 |
| The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin J Folch, I Patraca, N Martínez, I Pedrós, D Petrov, M Ettcheto, S Abad, ... Life sciences 140, 19-28, 2015 | 53 | 2015 |
| Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis E Verdaguer, S Brox, D Petrov, J Olloquequi, R Romero, ML de Lemos, ... Experimental gerontology 69, 176-188, 2015 | 47 | 2015 |
| Mavoglurant as a treatment for Parkinson’s disease D Petrov, I Pedros, ML de Lemos, M Pallas, AM Canudas, A Lazarowski, ... Expert opinion on investigational drugs 23 (8), 1165-1179, 2014 | 40 | 2014 |
| Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide J Folch, M Ettcheto, D Petrov, S Abad, I Pedrós, M Marin, J Olloquequi, ... Neurología 33 (1), 47-58, 2018 | 33 | 2018 |
| Hypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice M Ettcheto, D Petrov, I Pedrós, L de Lemos, M Pallas, M Alegret, ... Experimental Gerontology 65, 69-78, 2015 | 29 | 2015 |
| Evaluation of the role of JNK1 in the hippocampus in an experimental model of familial Alzheimer’s disease D Petrov, M Luque, I Pedrós, M Ettcheto, S Abad, M Pallàs, E Verdaguer, ... Molecular neurobiology 53, 6183-6193, 2016 | 26 | 2016 |
| Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer’s disease I Pedrós, D Petrov, G Artiach, S Abad, C Ramon-Duaso, F Sureda, ... The journal of nutrition, health & aging 19, 403-412, 2015 | 19 | 2015 |
| Molecular links between early energy metabolism alterations and Alzheimer’s disease I Pedros, I Patraca, N Martinez, D Petrov, FX Sureda, C Auladell, ... Front Biosci (Landmark Ed) 21, 8-19, 2016 | 11 | 2016 |
| CD166 (ALCAM) modulates inflammatory responses upon RAGE-ligand activation in vivo D Petrov, IK Lukic, JC Igwe, M Fabbi, S Ferrini, PP Nawroth, A Bierhaus DIABETOLOGIA 49, 413-414, 2006 | 1 | 2006 |
| ALCAM (CD166) contributes to inflammation in the footpad model of delayed type hypersensitivity D Petrov, J Igwe, PM Humpert, M Fabbi, S Ferrini, PP Nawroth, ... Diabetologie und Stoffwechsel 1 (S 1), A141, 2006 | | 2006 |
| PROTECTIVE EFFECTS AND ANTIINFLAMMATORY PATHWAY OF EXOGENOUS CGRP IN SEVERE NECROTIZING PANCREATITIS IN RATS L Schneider, W Hartwig, A Bierhaus, D Petrov, T Hackert, MM Gebhard, ... Pancreas 31 (4), 468, 2005 | | 2005 |
| # 143 Age-dependent changes in NF-κB binding activity in response to acute psychosocial stress JM Wolf, N Rohleder, A Bierhaus, D Petrov, PP Nawroth, C Kirschbaum Brain, Behavior, and Immunity 19 (4), e73-e74, 2005 | | 2005 |
